Peter Francis Minan Acquires 288 Shares of U.S. Physical Therapy (NYSE:USPH) Stock

U.S. Physical Therapy, Inc. (NYSE:USPH) Director Peter Francis Minan acquired 288 shares of the stock in a transaction that occurred on Tuesday, June 9th. The shares were bought at an average cost of $61.50 per share, with a total value of $17,712.00. Following the transaction, the director directly owned 3,211 shares in the company, valued at $197,476.50. This trade represents a 9.85% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Peter Francis Minan also recently made the following trade(s):

• On Monday, June 8th, Peter Francis Minan acquired 492 shares of U.S. Physical Therapy stock. The shares were bought at an average cost of $63.14 per share, with a total value of $31,064.88.

U.S. Physical Therapy Stock Performance

NYSE:USPH opened at $65.67 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. The stock has a market capitalization of $999.51 million, a P/E ratio of 131.34, a PEG ratio of 1.74 and a beta of 1.16. The company has a 50 day moving average price of $68.39 and a 200 day moving average price of $76.34. U.S. Physical Therapy, Inc. has a fifty-two week low of $58.19 and a fifty-two week high of $93.50.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 earnings per share for the quarter, missing analysts’ consensus estimates of $0.55 by ($0.09). The company had revenue of $198.29 million for the quarter, compared to analysts’ expectations of $200.94 million. U.S. Physical Therapy had a return on equity of 8.81% and a net margin of 4.36%.The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the business posted $0.48 EPS. Equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.99 EPS for the current year.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 22nd will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.84 dividend on an annualized basis and a dividend yield of 2.8%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 368.00%.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. JPMorgan Chase & Co. raised its holdings in shares of U.S. Physical Therapy by 106.9% in the 3rd quarter. JPMorgan Chase & Co. now owns 109,837 shares of the company’s stock valued at $9,331,000 after purchasing an additional 56,752 shares in the last quarter. William Blair Investment Management LLC raised its holdings in shares of U.S. Physical Therapy by 7.2% in the 4th quarter. William Blair Investment Management LLC now owns 370,707 shares of the company’s stock valued at $28,949,000 after purchasing an additional 24,848 shares in the last quarter. Bahl & Gaynor Inc. raised its holdings in shares of U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock valued at $40,325,000 after purchasing an additional 153,054 shares in the last quarter. M&T Bank Corp raised its holdings in shares of U.S. Physical Therapy by 172.7% in the 4th quarter. M&T Bank Corp now owns 28,676 shares of the company’s stock valued at $2,239,000 after purchasing an additional 18,159 shares in the last quarter. Finally, American Century Companies Inc. acquired a new stake in shares of U.S. Physical Therapy in the 3rd quarter valued at $21,940,000.

Analyst Upgrades and Downgrades

Several equities analysts have commented on USPH shares. Citigroup reissued an “outperform” rating on shares of U.S. Physical Therapy in a research report on Friday, May 8th. Barrington Research decreased their price target on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday, May 13th. Zacks Research raised shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $97.50.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.